explore -WSS

explore

author：leisure time 2025-09-03 15:26:13 - browse：37843

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： First Opinion Podcast: How to protect health care in times of war

WSS

First Opinion Podcast: How to protect health care in times of war

Readout Newsletter: New research from Sanofi, Regeneron, etc.

WHO may add ‘noma' to its list of neglected tropical diseases

Hilary may become 1st tropical storm to make landfall in California in 84 years

Baltimore teen accused of firing into crowd during block party mass shooting

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

hotspot

explore

entertainment

Bright Health sells Medicare Advantage business to Molina

Hilary may become 1st tropical storm to make landfall in California in 84 years

Hepatitis C has a cure — but many Americans still lack access to it

Chimpanzees, like humans and whales, get menopause: Study

Hepatitis C has a cure — but many Americans still lack access to it

The boys, now 6, who are gene therapy’s ‘edge case’ problem

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Chimpanzees, like humans and whales, get menopause: Study

Peter Hotez and the public health issue of online harassment

Hilary may become 1st tropical storm to make landfall in California in 84 years

explore

Congress must give Medicare recipients genetic counseling access

Eli Lilly to pay $200M for Beam’s stake in gene

Hilary expected to bring catastrophic, life

WHO may add ‘noma' to its list of neglected tropical diseases

As Maui death toll rises, number of missing remains unclear

FDA approves first treatment for ultra

entertainment

Wikipedia

entertainment

explore